Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elanco Animal Health IncELAN · Entity 3457 | Director | September 19, 2018 | September 19, 2018 |
| Zai Lab LtdZLAB · Entity 4271 | See Remarks | April 06, 2026 | April 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elanco Animal Health Inc
Report date September 19, 2018 · Filed September 19, 2018
This filing explicitly reported no securities owned.
Zai Lab Ltd
Report date April 06, 2026 · Filed April 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 117,602 |
Reported balance
After 2026-04-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-06 · Sale · Disposed 3,017 · Balance 117,602 F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2: These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units. |
Filing footnotes · ownership attribution and instrument terms
F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
F2: These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date February 08, 2021 · Filed February 11, 2021
Section 16 reporting ended · disclosed 2021-02-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 77,659 |
Reported balance
After 2021-02-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-02-08 · Grant · Acquired 25,409 · Balance 77,659 F1: Represents a payout of 75% of the 2018-2020 shareholder value award in connection with the Separation Agreement between Mr. Smiley and the Company dated February 8, 2021. |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 2,151 |
Reported balance
Holding disclosure · report date 2021-02-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,151 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a payout of 75% of the 2018-2020 shareholder value award in connection with the Separation Agreement between Mr. Smiley and the Company dated February 8, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2020 Filed Feb 13, 2020 23:17 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 19,266 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000046 · wf-form4_158163583321508.xml · derivative · entry 3 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,266 Underlying: Common Stock · 19,266 shares Expires 2021-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:17 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 5,447 | $144.25 | $785,729.75 |
DisclosureSEC source: 0000059478-20-000046 · wf-form4_158163583321508.xml · nonDerivative · entry 1 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,971 Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 19:06 UTC | ELI LILLY & Co LLY · Entity 2794 | PurchaseCommon Stock | 929 | $107.59 | $99,951.11 |
DisclosureSEC source: 0000059478-19-000287 · wf-form4_157228954632294.xml · nonDerivative · entry 1 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,524 Read SEC document |
| July 15, 2019 Filed Jul 15, 2019 19:46 UTC | ELI LILLY & Co LLY · Entity 2794 | PurchaseCommon Stock | 185 | $108.47 | $20,066.95 |
DisclosureSEC source: 0000059478-19-000218 · wf-form4_156321999834580.xml · nonDerivative · entry 1 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,595 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $108.00 to $109.09. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 05, 2019 Filed Jun 5, 2019 18:15 UTC | ELI LILLY & Co LLY · Entity 2794 | PurchaseCommon Stock | 426 | $118.03 | $50,280.78 |
DisclosureSEC source: 0000059478-19-000201 · wf-form4_155975850983762.xml · nonDerivative · entry 1 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,410 Read SEC document |
| February 04, 2019 Filed Feb 7, 2019 01:02 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 9,954 | $120.17 | $1,196,172.18 |
DisclosureSEC source: 0000059478-19-000069 · wf-form4_154950131872045.xml · nonDerivative · entry 1 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,983 Read SEC document |
| February 04, 2019 Filed Feb 20, 2019 20:40 UTC Amendment | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 9,955 | $120.17 | $1,196,292.35 |
DisclosureSEC source: 0000059478-19-000105 · wf-form4a_155069523325169.xml · nonDerivative · entry 1 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,984 F1 · shares: This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5. F1 · balance_after: This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5. Read SEC document |
| March 16, 2018 Filed Mar 20, 2018 16:06 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,000 | $79.20 | $237,600.00 |
DisclosureSEC source: 0000059478-18-000115 · wf-form4_152156199292929.xml · nonDerivative · entry 1 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,029 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2018. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 23:10 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 7,202 | $87.60 | $630,895.20 |
DisclosureSEC source: 0000059478-18-000049 · wf-form4_151744021514077.xml · nonDerivative · entry 1 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,029 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.